---
figid: PMC6851521__bsr-39-bsr20192453-g2
figtitle: The molecular mechanisms of LncRNA-correlated PKM2 in cancer metabolism
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Danio rerio
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
- Danio rerio
- Drosophila melanogaster
pmcid: PMC6851521
filename: bsr-39-bsr20192453-g2.jpg
figlink: /pmc/articles/PMC6851521/figure/F2/
number: F2
caption: (A) MEG3 promotes β-catenin degradation through a PTEN-dependent ubiquitin–proteasome
  system. Thus, MEG3 inhibits β-catenin activity through PKM2 reduction and PTEN increase.
  (B) LincRNA-p21 is a negative regulator of PKM2. The regulatory mechanism of PKM2
  mediated by LincRNA-p21 depends on the PTEN/AKT/mTOR cascade. (C) When HULC is overexpressed,
  HULC increases autophagy by increasing the expression of LC3I and LC3II. At the
  same time, HULC enhances the interaction between LC3 and ATG3. Thus, HULC inhibits
  PTEN through enhancing the cellular autophagy by increasing ubiquitin–proteasome
  dependent LC3II. The result is activation of the AKT-PI3K-mTOR pathway to inhibit
  tumor cell growth and metabolism when PTEN is reduced, based on inhibition of PTEN
  in liver cancer cells. Strikingly, HULC reduced the expression of PTEN, β-catenin
  and increased the expression of PKM2 in hematoma cells.
papertitle: The molecular mechanisms of LncRNA-correlated PKM2 in cancer metabolism.
reftext: Ting Tao, et al. Biosci Rep. 2019 Nov 29;39(11):BSR20192453.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9231645
figid_alias: PMC6851521__F2
figtype: Figure
redirect_from: /figures/PMC6851521__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6851521__bsr-39-bsr20192453-g2.html
  '@type': Dataset
  description: (A) MEG3 promotes β-catenin degradation through a PTEN-dependent ubiquitin–proteasome
    system. Thus, MEG3 inhibits β-catenin activity through PKM2 reduction and PTEN
    increase. (B) LincRNA-p21 is a negative regulator of PKM2. The regulatory mechanism
    of PKM2 mediated by LincRNA-p21 depends on the PTEN/AKT/mTOR cascade. (C) When
    HULC is overexpressed, HULC increases autophagy by increasing the expression of
    LC3I and LC3II. At the same time, HULC enhances the interaction between LC3 and
    ATG3. Thus, HULC inhibits PTEN through enhancing the cellular autophagy by increasing
    ubiquitin–proteasome dependent LC3II. The result is activation of the AKT-PI3K-mTOR
    pathway to inhibit tumor cell growth and metabolism when PTEN is reduced, based
    on inhibition of PTEN in liver cancer cells. Strikingly, HULC reduced the expression
    of PTEN, β-catenin and increased the expression of PKM2 in hematoma cells.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MEG3
  - NIBAN2
  - HULC
  - TP53COR1
  - PTEN
  - ATG3
  - GPM6A
  - METTL3
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - CTNNB1
  - MTOR
  - PKM
  - PKLR
  - Meg3
  - Niban2
  - Trp53cor1
  - Pten
  - Atg3
  - Mettl3
  - Gpm6a
  - Akt1
  - Pik3r1
  - Ctnnb1
  - Mtor
  - Pkm
  - Pik3cg
  - ptenb
  - atg3
  - ctnnb1
  - mtor
  - pkma
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - arm
  - Tor
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - MEG3
  - Cancer
---
